Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate the effect of Inclisiran on coronary atherosclerosis using intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in patients with acute myocardial infarction and elevated low-density lipoprotein cholesterol (LDL-C).


Clinical Trial Description

This study will be a multi-center, randomized, parallel-group, open-label, phase 4 study. Participants will be approximately 318 Chinese adults diagnosed with new-onset STEMI/NSTEMI and elevated LDL-C (LDL-C > 1.8 mmol/L if on stable dose of statin (with or without ezetimibe) for ≥ 4 weeks; LDL-C > 2.6 mmol/L if not on stable dose of statin (with or without ezetimibe) for ≥ 4 weeks). Participants will be 1:1 randomized to investigational group (Inclisiran 284mg + 20mg atorvastatin) or control group (20mg atorvastatin) for 360 days. Participants and investigator will be unblinded to the identity of the treatment from the time of randomization. Independent Review Committee (IRC) staff performing the study assessments (IVUS and OCT analysis) will be blinded to the identity of the treatment from the time of randomization until final database lock. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06372925
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Email novartis.email@novartis.com
Status Not yet recruiting
Phase Phase 4
Start date July 23, 2024
Completion date June 24, 2026

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03314818 - Natural History of Carotid Plaque as Determined by 3D Ultrasound N/A
Active, not recruiting NCT02374775 - Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamic N/A
Completed NCT01905566 - Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation Phase 4
Not yet recruiting NCT05753085 - Multimodality Optical and Ultrasound Intravascular Imaging for Stent Optimization and Atheroma Assessment N/A
Not yet recruiting NCT04524117 - Prediction of Vulnerable Plaque Using Coronary CT Angiography and Computational Fluid Dynamic in Acute Coronary Syndrome
Recruiting NCT05123287 - A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
Completed NCT02316886 - Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque Phase 4
Terminated NCT02009930 - Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
Recruiting NCT04922541 - Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
Not yet recruiting NCT06305559 - A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque Phase 3
Recruiting NCT03016910 - Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus. N/A
Completed NCT03064126 - RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty Phase 3
Recruiting NCT05550077 - Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Completed NCT02212470 - Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery Phase 4
Active, not recruiting NCT01899014 - 18F-choline PET-CT and MRI of Carotid Plaques Phase 3
Recruiting NCT04063709 - Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk N/A
Enrolling by invitation NCT06025305 - Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
Completed NCT01559493 - Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR) N/A
Active, not recruiting NCT04009421 - Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease
Recruiting NCT02640313 - Molecular Imaging of Plaque Vulnerability Phase 3